tiprankstipranks
Vectus Biosystems Limited (AU:VBS)
:VBS
Australian Market

Vectus Biosystems Limited (VBS) Price & Analysis

Compare
1 Followers

VBS Stock Chart & Stats


---

Financials

Quarterly

VBS FAQ

What was Vectus Biosystems Limited’s price range in the past 12 months?
Vectus Biosystems Limited lowest share price was AU$0.07 and its highest was AU$0.29 in the past 12 months.
    What is Vectus Biosystems Limited’s market cap?
    Vectus Biosystems Limited’s market cap is AU$4.05M.
      When is Vectus Biosystems Limited’s upcoming earnings report date?
      Vectus Biosystems Limited’s upcoming earnings report date is Aug 27, 2025 which is in 145 days.
        How were Vectus Biosystems Limited’s earnings last quarter?
        Vectus Biosystems Limited released its earnings results on Feb 21, 2025. The company reported -AU$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.021.
          Is Vectus Biosystems Limited overvalued?
          According to Wall Street analysts Vectus Biosystems Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Vectus Biosystems Limited pay dividends?
            Vectus Biosystems Limited does not currently pay dividends.
            What is Vectus Biosystems Limited’s EPS estimate?
            Vectus Biosystems Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Vectus Biosystems Limited have?
            Vectus Biosystems Limited has 53,278,313 shares outstanding.
              What happened to Vectus Biosystems Limited’s price movement after its last earnings report?
              Vectus Biosystems Limited reported an EPS of -AU$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Vectus Biosystems Limited?
                Currently, no hedge funds are holding shares in AU:VBS
                ---

                Vectus Biosystems Limited Stock Smart Score

                Company Description

                Vectus Biosystems Limited

                Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was incorporated in 2005 and is based in Rosebery, Australia.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Biotron Limited
                Paradigm Biopharmaceuticals Ltd.
                Immutep Ltd
                Prescient Therapeutics Limited
                Medical Developments International Limited
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis